À retenir
In 622 UK adults with poorly controlled hypertension, self-monitoring with the HOME BP digital intervention lowered systolic blood pressure by 3.4 mm Hg more than usual care at one year (95% CI -6.1 to -0.8). Diastolic pressure did not differ significantly (-0.5 mm Hg), and the trial was unmasked, so participants and doctors knew who used the programme.
Study design
Essai randomisé
Reading basis
Published abstract
Reading focus
Comparator & uncertainty
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Many people on treatment still have blood pressure above target. The authors tested whether combining home blood pressure monitoring with a guided online self-management programme, sharing results with both patient and professional, controls systolic pressure better than routine care.
Population et méthode
Unmasked randomised controlled trial in 76 UK general practices with 622 people with treated but poorly controlled hypertension (above 140/90 mm Hg) and internet access. Participants were randomised by a minimisation algorithm to self-monitoring with the digital intervention (305) or usual care (317). The primary outcome was systolic blood pressure (mean of second and third readings) after one year, adjusted for baseline pressure, target, age and practice, with multiple imputation for missing values.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1One-year data were available for 552 participants (88.6%), with imputation for the other 70 (11.4%).
- 2Mean blood pressure fell from 151.7/86.4 to 138.4/80.2 mm Hg with the intervention and from 151.6/85.3 to 141.8/79.8 mm Hg with usual care.
- 3The mean systolic difference was -3.4 mm Hg (95% CI -6.1 to -0.8) in favour of the intervention; the diastolic difference was -0.5 mm Hg (-1.9 to 0.9), a range that includes no effect.
- 4Complete case results were comparable, adverse effects were similar between groups, and the incremental cost effectiveness ratio was £11 (95% CI £6 to £29) per mm Hg reduction.
Limites et incertitude
- 1The trial was unmasked, so knowing the allocation could have influenced behaviour, although the primary endpoint was collected automatically.
- 2The 3.4 mm Hg gain is modest, and both groups improved a lot over the year, so the programme's added effect is small compared with the overall fall.
- 3The sample was limited to people with internet access, and the authors note that digitally excluded people need consideration.
- 4Missing one-year data for 70 participants were filled in by imputation.
Mise en perspective
A guided home-monitoring programme gave a modest extra drop in systolic pressure at low cost, and it may fit people who are comfortable online. It is not a substitute for medical care, and any change to blood pressure medicine should be made with your clinician.
Vos données
Home readings are the core of this approach: use a validated upper-arm cuff, sit quietly for a few minutes, and take readings at consistent times of day. Compare averages over several days rather than a single reading, and share the log with your GP or nurse.
Comprendre ce type de preuve
Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Objective
The HOME BP (Home and Online Management and Evaluation of Blood Pressure) trial aimed to test a digital intervention for hypertension management in primary care by combining self-monitoring of blood pressure with guided self-management.
Design
Unmasked randomised controlled trial with automated ascertainment of primary endpoint.
Setting
76 general practices in the United Kingdom.
Participants
622 people with treated but poorly controlled hypertension (>140/90 mm Hg) and access to the internet.
Interventions
Participants were randomised by using a minimisation algorithm to self-monitoring of blood pressure with a digital intervention (305 participants) or usual care (routine hypertension care, with appointments and drug changes made at the discretion of the general practitioner; 317 participants). The digital intervention provided feedback of blood pressure results to patients and professionals with optional lifestyle advice and motivational support. Target blood pressure for hypertension, diabetes, and people aged 80 or older followed UK national guidelines.
Main outcome measures
The primary outcome was the difference in systolic blood pressure (mean of second and third readings) after one year, adjusted for baseline blood pressure, blood pressure target, age, and practice, with multiple imputation for missing values.
Results
After one year, data were available from 552 participants (88.6%) with imputation for the remaining 70 participants (11.4%). Mean blood pressure dropped from 151.7/86.4 to 138.4/80.2 mm Hg in the intervention group and from 151.6/85.3 to 141.8/79.8 mm Hg in the usual care group, giving a mean difference in systolic blood pressure of -3.4 mm Hg (95% confidence interval -6.1 to -0.8 mm Hg) and a mean difference in diastolic blood pressure of -0.5 mm Hg (-1.9 to 0.9 mm Hg). Results were comparable in the complete case analysis and adverse effects were similar between groups. Within trial costs showed an incremental cost effectiveness ratio of £11 ($15, €12; 95% confidence interval £6 to £29) per mm Hg reduction.
Conclusions
The HOME BP digital intervention for the management of hypertension by using self-monitored blood pressure led to better control of systolic blood pressure after one year than usual care, with low incremental costs. Implementation in primary care will require integration into clinical workflows and consideration of people who are digitally excluded.
Trial registration
ISRCTN13790648.
Sources et attribution
Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial.
McManus RJ, Little P, Stuart B, Morton K, Raftery J, Kelly J, Bradbury K, Zhang J, Zhu S, Murray E, May CR, Mair FS, Michie S, Smith P, Band R, Ogburn E, Allen J, Rice C, Nuttall J, Williams B, Yardley L, HOME BP investigators.
BMJ (Clinical research ed.) · 2021-01-19
DOI: 10.1136/bmj.m4858 ↗PubMed · 33468518 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people
Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.
Journal of the American Heart Association
Five exercise types lowered resting blood pressure, isometric training the most
Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.
British Journal of Sports Medicine
A salt substitute lowered stroke, major cardiovascular events and death in rural China
In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.
The New England Journal of Medicine
Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation
Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.
The New England Journal of Medicine

